Visceral childhood leishmaniasis: Diagnosis and treatment;Diagnóstico y tratamiento de la leishmaniasis visceral infantil

Anales de Pediatria

Volumn 72, Issue 5, 2010, Pages 347-351

  Prieto Tato, L M ^a   La Orden Izquierdo, E ^a   Guillen Martn S ^a   Salcedo Lobato, E ^a   Garcia Esteban C ^a   Garca Bermejo, I ^a   Ramos Amador, J T ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Diagnosis; Liposomal amphotericin B; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; MEGLUMINE ANTIMONATE;

ADOLESCENT; AMASTIGOTE; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEVER; HEPATOMEGALY; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; LEISHMANIA; LEUKOPENIA; MEDICAL RECORD; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SPAIN; SPLENOMEGALY; TERTIARY HEALTH CARE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISCERAL LEISHMANIASIS;

ADOLESCENT; AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 77952242200     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2009.12.020     Document Type: Article

References (18)

1. Y. Valcrcel, R. Bastero, M. Anegn, S. Gonzlez, and A. Gil Epidemiologa de los ingresos hospitalarios por leishmaniasis en España (19992003) Enferm Infecc Microbiol Clin 26 2008 278 281
2. E. Ortega-Barria, and L.I. Romero Leishmania species (Leishmaniasis) S. Long, L.K. Pickering, C.G. Prober, Principles and practice of Pediatric Infectious Diseases 3 ed 2008 Elselvier Inc Piladelphia, USA 1246 1253
3. R. Reithinger, and J.C. Dujardin Molecular diagnosis of leishmaniasis: Current status and future applications J Clin Microbiol 45 2007 21 25
4. I. Cruz, C. Chicharro, J. Nieto, B. Bailo, C. Caavate, and M.C. Figueras Comparison of new diagnostic tools for the management of pediatric mediterranean visceral leishmaniasis J Clin Microbiol 44 2006 2343 2347
5. Z.J. Attar, M.L. Chance, S. El-Safi, J. Carney, A. Azazy, and M. El-Hadi Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis Acta Trop 78 2001 11 16
6. S. Rijal, M. Boelaert, S. Regmi, M. Karki, D. Jacquet, and R. Singh Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal Trop Med Int Health 9 2004 724 729
7. R.N. Davidson, S.L. Croft, A. Dcott, M. Maini, A.H. Moody, and A.D.M. Bryceson Liposomal amphotericin B in drug-resistant visceral leishmaniasis Lancet 337 1991 1061 1062
8. R.N. Davidson, L. Di Martino, L. Gradoni, R. Giacochino, G.B. Greta, and R. Pempirello Short course treatment of visceral leishmaniasis with liposomal amphotericin B Clin Infect Dis 22 1996 938 993
9. L. Di Martino, R.N. Davidson, R. Giachino, S. Scotti, F. Raimondi, and E. Castagnola Treatment of visceral leishmaniasis in children with liposomal amphotericin B J Pediatr 131 1997 271 277
10. H.C. Maltezou, C. Siafas, M. Mavrikou, P. Spyridis, C. Stavrinadis, and Th. Karpathios Visceral leishmaniasis during childhood in southern Greece Clinical Infectious Diseases 31 2000 1139 1143
11. A. Cascio, C. Colomba, S. Antinori, M. Orobello, D. Paterson, and L. Titone Pediatric visceral leishmaniasis in western Sicily, Italy: A retrospective anlisis of 111 cases Eur J Clin Microbiol Infect Dis 21 2002 277 282
12. M. Boelaert, S. Rijal, S. Regmi, R. Singh, B. Karki, and D. Jacquet A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis Am J Trop Med Hyg 70 2004 72 77
13. H.W. Murray Treatment of visceral leishmaniasis (kala-azar): A decade of progress and future approaches International Journal of Infectious Diseases 4 2000 158 177
14. B.L. Herwaldt, and J.D. Berman Recommendation for treating leishmaniasis with Pentostan and review of pertinent clinical studies Am J Trop Med Hyg 46 1992 296 306
15. B.L. Herwaldt Leishmaniasis Lancet 354 1999 1191 1199
16. S. Sundar, D.K. More, M.K. Singh, V.P. Singh, S. Sharma, and A. Makharia Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic Clin Infect Dis 31 2000 1104 1107
17. A. Meyerhoff US Food and Drug Administration approval of Ambisome for treatment of visceral leishmaniasis Clin Infect Dis 28 1999 42 44
18. D.A. Kafetzis, I.M. Velissariou, S. Stabouli, M. Mavrikou, D. Delis, and G. Liapi Treatment of paediatric visceral leishmaniasis: Amphotericin B or pentavalent antimony compounds? Int J Antimicrob Agent 25 2005 26 30